Breaking News Updates for the Psychedelics Industry | Page 8 of 9

Psychedelics News

Breaking News

Breaking News, Industry

1 Mar 2022

Calgary-based Med Plant Science Ltd. granted license to research and develop psychedelics in St Vincent and the Grenadines

Calgary-based biotech company, Med Plant Science Ltd, has been awarded a license for medicinal plants containing psychedelic compounds by the St....

By Microdose

Breaking News

21 Feb 2022

Cathie Wood and ARK Increase Support for Psychedelics

ARKG has increased their investment approx 4-fold, buying ATAI an additional 4 times and bringing their total to over 340,000 shares (approx $2 million at current value)....

By Jason Najum

Breaking News, Science

16 Feb 2022

Johns Hopkins Study Shows Psilocybin Effective for a Year

A new study by Johns Hopkins Medicine shows that the antidepressant effects of psilocybin (with psychotherapy) can last at least a year after treatment....

By Jason Najum

Breaking News, Industry

15 Feb 2022

Cybin Inks Deal w Chopra Foundation. Gets Praise From Tony Robbins

The partnership with Chopra will help the sector and in particular, Cybin, who will benefit from the association with this headline name....

By Jason Najum

Join Our Newsletter for Exclusive Updates, Stories, and More

Breaking News, Industry

9 Feb 2022

Cybin Granted DMT Patent for CYB004

Developing and securing intellectual property is one of the most important tasks of a psychedelic medicine firm....

By Jason Najum

Breaking News, Law & Politics

4 Feb 2022

Breaking News: Health Canada Denies Psilocybin Access

The federal government has just denied dozens of health care professionals seeking psilocybin access and training under section 56 exemption application....

By Jason Najum

Breaking News

25 Jan 2022

Breaking News: FDA Clears MindMed’s Phase 2b LSD Trial

FDA clearance leads to first commercial IND for LSD, enabling MinfdMed to start Phase 2b dose-optimization trial in early 2022...

By Jason Najum

Breaking News

11 Jan 2022

Awakn Announces Positive Results from Phase II Trial of Alcohol Use Disorder

Primary and Secondary Endpoints Achieved, Including 86% Abstinence Over 6 Months Post Treatment and No Serious Adverse Events...

By Microdose

Breaking News, Industry

15 Nov 2021

MindMed Announces Financial Results and Business Highlights

Quarterly updates are important tools to not only stay updated on a company’s progress but to remind us that an absence of headlines doesn’t mean a lack of progress....

By Jason Najum

Follow us on social

Latest News

Trump’s Psychedelic Fast-Track Order Changes the Timeline. It Also Redraws the Competitive Map.

AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy

Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy

Professional Training in Psychedelic Medicine

Psychedelic medicine is reshaping the future of mental health care. From the power of microdosing LSD to the promise of MDMA in PTSD, the world of medical psychedelics offers transformative possibilities. Our comprehensive, CE-accredited course provides you with the knowledge and understanding you need to tap into this groundbreaking field.

WordPress Ads

No Result

View All Result